Craig Venter says his company has uncovered disease in people who otherwise appeared healthy, HealthcareITNews reports.
Researchers have argued that the facial prediction claims are overblown and serve Human Longevity's financial interests in proprietary genomic databases.
In PNAS this week: trait prediction algorithm, missense mutation linked to hearing loss, and more.
Using a new algorithm, JCVI and Human Longevity researchers revealed potential re-identification risks using trait prediction from genome sequences.
The companies are aiming to identify treatment-response biomarker signatures in patients with advanced melanoma.
In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.
Massachusetts Mutual Life Insurance-associated patients can have their doctor order the HLIQ Whole Genome sequencing test for $1,400.
This month, GWG Life began sending out cheek swab kits to life insurance policy holders to analyze their saliva for epigenetic biomarkers developed at UCLA.
A GWAS of blood metabolite patterns in identical and non-identical twins led to common, low-frequency, and rare variants influencing metabolite levels
In PNAS this week: mutation patterns in uterine and ovarian carcinosarcomas, deep genome sequences, and more.
CNN reports that researchers have tied a new variant to opioid addiction risk.
Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.
An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.
In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.